# Pfizer Healthcare India Private Limited, Visakhapatnam, India – FDA Inspections

Source: https://www.keypedia.com/companies/pfizer-healthcare-india-private-limited/50c6f34f-3ef8-4cd6-bd55-6e1ee280d4f7

> Inspection records and compliance data for Pfizer Healthcare India Private Limited in Visakhapatnam. 8 FDA inspections on record (1 OAI), 4 Form 483s, 1 warning letter, last inspected September 10, 2026.

---

## Details

- Name: Pfizer Healthcare India Private Limited
- FEI Number: 3008316085
- Business Operations: FDF MANUFACTURE
- Address Line 1: Plots 116-117-118-119-111-123(Part), Jawaharlal Nehru Pharma City - Sez, Parawada
- City: Visakhapatnam
- Country Name: India
- Address: Plots 116-117-118-119-111-123(Part), Jawaharlal Nehru Pharma City - Sez, Parawada, Visakhapatnam, India
- Country: India

## Related Documents

- [483 - Pfizer Healthcare India Private Limited - Unknown Date](https://www.keypedia.com/records/483/pfizer-healthcare-india-private-limited/e45ea7f9-20fb-44a2-a86d-3286a7d8a034) — source: FDA, date: Invalid Date
- [FDA Inspection 1335052 - Pfizer Healthcare India Private Limited - 2026-09-10](https://www.keypedia.com/records/fda_inspections/pfizer-healthcare-india-private-limited/5a7580b0-2f3d-4759-a735-dae72d1335b7) — source: FDA, date: September 10, 2026
- [483 - Pfizer Healthcare India Private Limited - 2022-10-18](https://www.keypedia.com/records/483/pfizer-healthcare-india-private-limited/d4990f8b-8170-4751-8910-2b4c040a6367) — source: FDA, date: October 18, 2022
- [FDA Inspection 1181610 - Pfizer Healthcare India Private Limited - 2022-10-18](https://www.keypedia.com/records/fda_inspections/pfizer-healthcare-india-private-limited/f7adf7eb-8fa7-4607-a49a-cd847f06d612) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 18, 2022
- [WARNING_LETTER - Pfizer Healthcare India Private Limited - 2019-09-06](https://www.keypedia.com/records/warning_letter/pfizer-healthcare-india-private-limited/5f96070a-9d0d-4a20-a254-22cfb2546131) — source: FDA, date: September 6, 2019
- [FDA Inspection 1106244 - Pfizer Healthcare India Private Limited - 2019-09-06](https://www.keypedia.com/records/fda_inspections/pfizer-healthcare-india-private-limited/d661c7f5-6120-4820-af7a-3caf6f60c2b8) — classification: Official Action Indicated (OAI), source: FDA, date: September 6, 2019
- [483 - Pfizer Healthcare India Private Limited - 2019-09-02](https://www.keypedia.com/records/483/pfizer-healthcare-india-private-limited/4dbc165b-d356-4c51-94d9-c86ffd9c3e34) — source: FDA, date: September 2, 2019
- [483 - Pfizer Healthcare India Private Limited - 2018-09-21](https://www.keypedia.com/records/483/pfizer-healthcare-india-private-limited/3c3051ca-5bac-49f1-bd87-de0e740dc4f4) — source: FDA, date: September 21, 2018
- [FDA Inspection 1066469 - Pfizer Healthcare India Private Limited - 2018-09-21](https://www.keypedia.com/records/fda_inspections/pfizer-healthcare-india-private-limited/aeb76de0-90d1-49f4-8250-f4b01568e8eb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 21, 2018
- [FDA Inspection 1006274 - Pfizer Healthcare India Private Limited - 2017-03-17](https://www.keypedia.com/records/fda_inspections/pfizer-healthcare-india-private-limited/f7746b54-915d-4d84-9204-6716c9d54700) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 17, 2017
- FDA Inspection 941107 - Pfizer Healthcare India Private Limited - 2015-09-08 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 8, 2015
- FDA Inspection 917613 - Pfizer Healthcare India Private Limited - 2015-02-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 25, 2015
- FDA Inspection 871523 - Pfizer Healthcare India Private Limited - 2014-03-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2014

## Related Companies

- [NATCO Pharma Limited](https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/66c964bb-f670-493b-ab86-aa8507e68a5d)
- [Ascent Pharmaceuticals Inc](https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/4fd10a2e-3696-4bd0-82aa-e875143028c0)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/de9dc5de-fbea-4a7d-ab5b-a398b6ed442e)
- [GRANULES LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/granules-life-sciences-private-limited/434955b0-03c5-4fc0-a6c2-1241872c2974)
- [Modavar Pharmaceuticals](https://www.keypedia.com/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)
- [Aarkish Pharmaceuticals NJ Inc](https://www.keypedia.com/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)
- [Procter & Gamble Manufactura S. de R.L. de C.V.](https://www.keypedia.com/companies/procter-gamble-manufactura-s-de-rl-de-cv/8b78eeab-6efe-4a8d-b98a-c1bfda966646)

## Related Officers

- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [issuing_officer](https://www.keypedia.com/people/toyin-b-oladimeji/0aff4ab4-a1ff-4394-a32d-747bdc5f248b)
- [Samina S. Khan](https://www.keypedia.com/people/samina-s-khan/ca3e266c-aa69-4c28-9901-d344e0c259fd)
- [Quality System Specialist](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)